In 2022, the Japanese Ministry of Health, Labor, and Welfare revised medical service fees, covering genetic testing for mitochondrial diseases under medical insurance plans. The Center for Diagnosis ...
Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for treating intractable intestinal diseases due to their low risk of rejection ...
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving ...
Breakthrough in Intractable Intestinal Disease Treatment Using Xenogeneic-Free Intestinal Stem Cells
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...
Researchers in Tokyo have broken ground in a gene therapy delivery method for diseases of the brain and central nervous system, and regenerative medicine for the intestinal tract. For more than a ...
CAMBRIDGE, England--(BUSINESS WIRE)--Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced the appointment of Dr James Osborne as Head of Chemistry and ...
Curamys to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to help advance its cell fusion technology. ROCKVILLE, Md. and SEOUL, South Korea, Dec. 04, 2022 (GLOBE NEWSWIRE) -- ...
The incidence of inflammatory bowel disease (IBD) - an intractable disease characterized by chronic inflammation of the gastrointestinal (GI) tract - has increased significantly in Japan. Chronic ...
SYDNEY, March 21, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an exclusive licensing ...
Understanding the molecular and biological diversity of rare diseases due to accumulated triglycerides and contributing to the global network of researchers, clinical practitioners, and patients Osaka ...
The human genome is driving healthcare innovation, and the biopharmaceutical industry is increasingly focusing research and development centered on understanding the role of genetics in health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results